retinal disease

FDA grants orphan drug designation to HuidaGene gene therapy for blindness
Pharmaceutical Business Review
Tue, 04/4/23 - 12:25 pm
HuidaGene
HG004
gene therapy
FDA
retinal disease
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
JNJ
gene therapy
clinical trials
retinal disease
MeiraGTx
X-linked retinitis pigmentosa
Biogen, Samsung Bioepis launch ranibizumab-nuna in US
Ophthalmology Today
Fri, 06/3/22 - 09:11 am
Biogen
Samsung Bioepis
ranibizumab
ranibizumab-nuna
biosimilars
Roche
Lucentis
retinal disease
Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact
Fierce Biotech
Wed, 04/6/22 - 12:18 pm
Regeneron
gene therapy
ViGeneron
retinal disease
AbbVie, Regenxbio enter deal to develop retinal disease therapy
Reuters
Mon, 09/13/21 - 10:29 am
AbbVie
Regenxbio
RGX-314
gene therapy
retinal disease
Boehringer Ingelheim signs retinal disease deal with Inflammasome
Pharmaceutical Business Review
Tue, 09/24/19 - 09:26 am
Boehringer Ingelheim
Inflammasome Therapeutics
retinal disease
Syncona gene therapy start-ups Gyroscope, Orbit merge
BioCentury
Thu, 04/11/19 - 07:16 pm
Syncona
Gyroscope
Orbit
gene therapy
retinal disease
M&A
After J&J retinal deal, MeiraGTx raises $80M for unpartnered programs
BioCentury
Wed, 02/27/19 - 07:16 pm
MeiraGTx
JNJ Innovation
gene therapy
retinal disease
Regeneron Pharma and Bayer begin late-stage trial of eye drug Eylea in China
Yahoo/AP
Mon, 11/28/11 - 11:41 am
Regeneron
Bayer
Eyelea
China
retinal disease
Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Yahoo/AP
Wed, 05/4/11 - 08:45 pm
Allergan
Molecular Partners
retinal disease